Literature DB >> 7706453

The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.

D A Albert1.   

Abstract

Myc is implicated in the control of growth in a variety of cell types. I investigated c-myc gene expression in several lymphoid cell lines to determine the response to cyclic AMP. Cyclic AMP causes a precipitous decline in c-myc message concentration that precedes G1 cell cycle arrest in wild type S49 cells but not in KIN- cells that lack cAMP dependent PKA activity. In wild-type S49 cells washout of cyclic AMP restores c-myc message levels within 2 h but does not relieve the G1 arrest until 10 h later. Transcription runoff studies demonstrate inhibition of both transcriptional initiation and prolongation of initiated transcripts. However, the degree of inhibition is insufficient to explain the absence of detectable myc message suggesting that the predominant effect of cyclic AMP is to destabilize the c-myc message. In contrast to wild-type cells, the "Deathless" mutant S49 cell line is viable when arrested in G1 by exposure to cyclic AMP and has preserved c-myc expression. Thus, in S49 cells down regulation of c-myc expression appears to be associated with loss of viability rather than G1 cell cycle arrest. Interestingly, CEM human T lymphoma cells do not arrest in G1 phase when exposed to cyclic AMP in spite of losing detectable c-myc gene expression. This suggests that in some T lymphoma cells c-myc gene expression may not be necessary for cell cycle progression and proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706453      PMCID: PMC295631          DOI: 10.1172/JCI117820

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines.

Authors:  M Jücker; M Schaadt; V Diehl; S Poppema; D Jones; H Tesch
Journal:  Hematol Oncol       Date:  1990 Jul-Aug       Impact factor: 5.271

Review 2.  Control of c-myc regulation in normal and neoplastic cells.

Authors:  C A Spencer; M Groudine
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

3.  Max: functional domains and interaction with c-Myc.

Authors:  G J Kato; W M Lee; L L Chen; C V Dang
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

4.  Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB.

Authors:  J L Meinkoth; M R Montminy; J S Fink; J R Feramisco
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

Review 5.  Multiple determinants of eukaryotic mRNA stability.

Authors:  D W Cleveland; T J Yen
Journal:  New Biol       Date:  1989-11

6.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

8.  cis-acting determinants of c-myc mRNA stability.

Authors:  M D Cole; S E Mango
Journal:  Enzyme       Date:  1990

9.  Premature termination of transcription from the P1 promoter of the mouse c-myc gene.

Authors:  S Wright; L F Mirels; M C Calayag; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.

Authors:  D Eick
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

View more
  3 in total

1.  Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.

Authors:  N Kvirkvelia; I Vojnovic; T D Warner; V Athie-Morales; P Free; N Rayment; B M Chain; T W Rademacher; T Lund; I M Roitt; P J Delves
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells.

Authors:  Lingzhi Zhang; Alexander C Zambon; Karen Vranizan; Kanishka Pothula; Bruce R Conklin; Paul A Insel
Journal:  J Biol Chem       Date:  2007-11-29       Impact factor: 5.157

3.  Quantitative proteomics analysis of the cAMP/protein kinase A signaling pathway.

Authors:  Yurong Guo; Andrea Wilderman; Lingzhi Zhang; Susan S Taylor; Paul A Insel
Journal:  Biochemistry       Date:  2012-11-12       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.